
Publikationen von Udo Reichl
Alle Typen
Zeitschriftenartikel (268)
1.
Zeitschriftenartikel
13 (5), 1286 (2025)
Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production. Processes 2.
Zeitschriftenartikel
12 (7), 755 (2024)
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 3.
Zeitschriftenartikel
108 (1), 240 (2024)
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 4.
Zeitschriftenartikel
15, 1434301 (2024)
Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry. Frontiers in Microbiology 5.
Zeitschriftenartikel
4 (1), ycae153 (2024)
Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins. ISME Communications 6.
Zeitschriftenartikel
250, 121020 (2024)
Breakdown of hardly degradable carbohydrates (lignocellulose) in a two-stage anaerobic digestion plant is favored in the main fermenter. Water Research 7.
Zeitschriftenartikel
81, S. 10 - 25 (2024)
Model-based optimization of cell-free enzyme cascades exemplified for the production of GDP-fucose. Metabolic Engineering 8.
Zeitschriftenartikel
20 (5), e1012190 (2024)
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens 9.
Zeitschriftenartikel
17, 66 (2024)
Improved biological methanation using tubular foam-bed reactor. Biotechnology for Biofuels and Bioproducts 10.
Zeitschriftenartikel
108, 97 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 11.
Zeitschriftenartikel
27 (4), 109421 (2024)
Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 12.
Zeitschriftenartikel
24 (4), 2300245 (2024)
From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 13.
Zeitschriftenartikel
20 (1), 2373521 (2024)
Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations. Human Vaccines & Immunotherapeutics 14.
Zeitschriftenartikel
24 (21), e202300463 (2023)
A Cell‐Free Multi‐enzyme Cascade Reaction for the Synthesis of CDP‐Glycerol. ChemBioChem: A European Journal of Chemical Biology 15.
Zeitschriftenartikel
28 (4), 1843 (2023)
Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation. Molecules 16.
Zeitschriftenartikel
26, S. 132 - 150 (2023)
Removable Dyes—The Missing Link for In-Depth N-glycan Analysis via Multi-Method Approaches. Engineering 17.
Zeitschriftenartikel
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports 18.
Zeitschriftenartikel
120 (9), S. 2639 - 2657 (2023)
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 19.
Zeitschriftenartikel
120, S. 3335 - 3346 (2023)
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 20.
Zeitschriftenartikel
107, S. 5947 - 5961 (2023)
Production of retroviral vectors in continuous high cell density culture. Applied Microbiology and Biotechnology